findmyKOL
Clinical trialNCT04043676UnknownPhase 2Interventional

Consolidation Treatment With Ponatinib 15 mg on Treatment Free-Remission Rate in Patients With Chronic Myeloid Leukemia

SponsorFundación Teófilo Hernando, SpainEnrollment40Chronic Myeloid Leukemia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Spain
  • Hospital Trials I Pujol

    Badalona, Barcelona, Spain

    Recruiting
  • Hospital Vall D'Hebron

    Barcelona, Spain

    Recruiting
  • Hospital Universitario de Gran Canarias Dr. Negrin

    Las Palmas de Gran Canaria, Spain

    Recruiting
  • Hospital Universitario Doce de Octubre

    Madrid, Spain

    Recruiting
  • Hospital Universitario Ramon Y Cajal

    Madrid, Spain

    Recruiting
  • Hospital Unversitario de la Princesa

    Madrid, Spain

    Recruiting
  • Hospital Regional de Malaga

    Málaga, Spain

    Recruiting
  • Hospital Universitario de Salamanca

    Salamanca, Spain

    Recruiting
  • Hospital Clinico Universitario de Valencia

    Valencia, Spain

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2019
Primary completion
30 Apr 2022
Completion
30 Apr 2023
Last update posted
2 Aug 2019
Registered enrollment
40
Registry id
NCT04043676

Cross-registrations

EU-CTR / CTIS (EudraCT)2017-004565-27

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.